David J. Cowan
GlaxoSmithKline (United States) · 19 works · 1,164 citations · h-index 12
Top works
- The Structure−Activity Relationship between Peroxisome Proliferator-Activated Receptor γ Agonism and the Antihyperglycemic Activity of Thiazolidinediones
- Design of Selective and Soluble Inhibitors of Tumor Necrosis Factor-α Converting Enzyme (TACE)
- Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors
- N-Hydroxyformamide peptidomimetics as TACE/Matrix metalloprotease inhibitors: oral activity via P1′ isobutyl substitution
- Phosphodiesterase Type IV Inhibition. Structure-Activity Relationships of 1,3-Disubstituted Pyrrolidines
- Discovery of a Highly Potent, Nonabsorbable Apical Sodium-Dependent Bile Acid Transporter Inhibitor (GSK2330672) for Treatment of Type 2 Diabetes
- Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38
- Substrate Specificity and Novel Selective Inhibitors of TNF-α Converting Enzyme (TACE) from Two-Dimensional Substrate Mapping
- Enzymatic- and Iridium-Catalyzed Asymmetric Synthesis of a Benzothiazepinylphosphonate Bile Acid Transporter Inhibitor
- The human ACC2 CT-domain C-terminus is required for full functionality and has a novel twist
- Phosphodiesterase type IV (PDE IV) inhibition. Synthesis and evaluation of a series of 1,3,4-trisubstituted pyrrolidines
- TNFα converting enzyme
- Hantzsch Synthesis of Pyrazolo[1‘,2‘:1,2]pyrazolo[3,4-b]pyridines: Partial Agonists of the Calcitonin Receptor
- Exploration of phenylpropanoic acids as agonists of the free fatty acid receptor 4 (FFA4): Identification of an orally efficacious FFA4 agonist
- Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration
- CCDC 1421936: Experimental Crystal Structure Determination
- Screening And Design Of Tumor Necrosis Factor-
- ChemInform Abstract: Design and Synthesis of Conformationally Constrained Analogues of 4‐(3‐ Butoxy‐4‐methoxybenzyl)imidazolidin‐2‐one (Ro 20‐1724) as Potent Inhibitors of cAMP‐Specific Phosphodiesterase.
- ChemInform Abstract: Enzymatic‐ and Iridium‐Catalyzed Asymmetric Synthesis of a Benzothiazepinylphosphonate Bile Acid Transporter Inhibitor.